Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Cash from Financing Activities: 2011-2024

Historic Cash from Financing Activities for Cryo Cell International (CCEL) over the last 14 years, with FY2024 value amounting to -$979118.0.

  • Cryo Cell International's Cash from Financing Activities fell 7194.4% to -$3.5 million in Q3 2025 from the same period last year, while for Aug 2025 it was -$4.8 million, marking a year-over-year decrease of 212484.2%. This contributed to the annual value of -$979118.0 for FY2024, which is 5276.56% up from last year.
  • Latest data reveals that Cryo Cell International reported Cash from Financing Activities of -$979118.0 as of FY2024, which was up 5276.56% from -$2.1 million recorded in FY2023.
  • Over the past 5 years, Cryo Cell International's Cash from Financing Activities peaked at $147862.0 during FY2022, and registered a low of -$5.0 million during FY2020.
  • For the 5-year period, Cryo Cell International's Cash from Financing Activities averaged around -$2.2 million, with its median value being -$2.1 million (2023).
  • In the last 5 years, Cryo Cell International's Cash from Financing Activities skyrocketed by 10481.17% in 2022 and then crashed by 150190.92% in 2023.
  • Over the past 5 years, Cryo Cell International's Cash from Financing Activities (Annual) stood at -$5.0 million in 2020, then surged by 38.59% to -$3.1 million in 2021, then soared by 104.81% to $147862.0 in 2022, then plummeted by 1501.91% to -$2.1 million in 2023, then skyrocketed by 52.77% to -$979118.0 in 2024.
  • Its Cash from Financing Activities was -$979118.0 in FY2024, compared to -$2.1 million in FY2023 and $147862.0 in FY2022.